You are viewing the "Alison Kodjak | NPR" Archives
The rule strengthens protections for health care providers who are unwilling to provide services like abortions. Critics say it could put women’s health in danger.
The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration’s call to tie prices to what other nations pay might work better.
A little-noticed Trump administration proposal would require hospitals, doctors and insurers to post the true, negotiated price for a medical procedure or service, as opposed to the “list” price.
Remarkably little is known about the fundamentals of how a woman carries a baby inside her. Two Columbia University researchers aim to change that, to reduce the number of kids born too soon.
Pharmacy benefit managers are the focus of proposed regulations that could reduce drug costs for seniors and cut profits for middlemen. It could set a precedent for the broader market.
Congressional Democrats want to protect health coverage and protections of the Affordable Care Act. With the Senate in Republican hands, House Democrats will hold hearings and may turn to the courts.
To protect a developing fetus from experimental drugs or treatments that might cause birth defects, pregnant women aren’t included in many clinical trials. But that limits the safety evidence, too.
Throughout the U.S., subsidies are available to reduce the price of 2019 policies sold on state and federal insurance exchanges. But promotion of the insurance is varying widely from state to state.
In signs the health care market may be maturing, an analysis of insurance filings shows premiums will rise less than 4 percent on average and companies plan to market more policies in more places.
Celgene Corp. has thwarted rival drugmakers eager to make cheaper versions of medicines for a form of blood cancer. Now administration officials are criticizing practices they say hold generics back.